Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism.
Widner
H
H
Department of Neurology, Lund University Hospital, Sweden.
Tetrud
J
J
Rehncrona
S
S
Snow
B J
BJ
Brundin
P
P
Björklund
A
A
Lindvall
O
O
Langston
J W
JW
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000009:adverse effects*; D000203:Activities of Daily Living; D000328:Adult; D016380:Brain Tissue Transplantation / Q000502:physiology*; D004292:Dominance, Cerebral / Q000187:drug effects / Q000502:physiology*; D005260:Female; D016332:Fetal Tissue Transplantation / Q000502:physiology*; D005500:Follow-Up Studies; D005684:Gait / Q000187:drug effects; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D008297:Male; D008636:Mesencephalon / Q000196:embryology / Q000637:transplantation*; D008875:Middle Aged; D009460:Neurologic Examination / Q000187:drug effects; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000503:physiopathology / Q000601:surgery
D007980:Levodopa; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine